Literature DB >> 12725362

Mupirocin resistance in clinical isolates of Staphylococcus aureus.

Paula G Jones1, Terri Sura, Michael Harris, Anne Strother.   

Abstract

One hundred isolates of Staphylococcs aureus were collected in a laboratory serving several hospitals and clinics in southeastern Wisconsin and tested for mupirocin susceptibility. Only two isolates of S. aureus showed mupirocin resistance. The mupirocin-resistant isolates were from hospitalized patients with positive blood cultures.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12725362     DOI： 10.1086/502204

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  4 in total

1.  Blueprint for antimicrobial hit discovery targeting metabolic networks.

Authors:  Y Shen; J Liu; G Estiu; B Isin; Y-Y Ahn; D-S Lee; A-L Barabási; V Kapatral; O Wiest; Z N Oltvai
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-05       Impact factor: 11.205

2.  Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population.

Authors:  Jacob S Hogue; Patricia Buttke; LoRanee E Braun; Mary P Fairchok
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

3.  Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States.

Authors:  Adriana Cadilla; Michael Z David; Robert S Daum; Susan Boyle-Vavra
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

4.  Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa.

Authors:  Adebayo O Shittu; Edet E Udo; Johnson Lin
Journal:  BMC Infect Dis       Date:  2009-01-28       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.